pyridostigmine bromide has been researched along with arginine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (75.00) | 18.2507 |
| 2000's | 5 (15.63) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Arvat, E; Boffano, GM; Boghen, MF; Ghigo, E; Goffi, S; Imperiale, E; Magliona, A; Mazza, E; Santi, I; Valetto, MR | 1 |
| Arvat, E; Bellone, J; Boffano, GM; Cappa, M; De Sanctis, C; Ghigo, E; Imperiale, E; Loche, S; Mazza, E; Valetto, MR | 1 |
| Frohman, LA; Kelijman, M | 1 |
| Bellone, J; Camanni, F; De Sanctis, C; Ghigo, E; Imperiale, E; Lala, R; Mazza, E; Procopio, M; Valente, F | 1 |
| Casanueva, FF; Cordido, F; Dieguez, C | 1 |
| Arvat, E; Camanni, F; Deghenghi, R; Di Vito, L; Ghigo, E; Gianotti, L; Imbimbo, BP; Lenaerts, V | 1 |
| Camanni, F; Cavagnini, F; Ghigo, E; Grottoli, S; Invitti, C; Maccario, M; Procopio, M | 1 |
| Bento, A; Dieguez, C; Mota, A; Peñalva, A; Pombo, M | 1 |
| Arvat, E; Avagnina, S; Bellitti, D; Camanni, F; Ghigo, E; Gianotti, L; Müller, EE; Nicolosi, M; Rolla, M; Valetto, MR | 1 |
| Arvat, E; Camanni, F; Ghigo, E; Gianotti, L; Maccario, M; Ramunni, J | 1 |
| Dieguez, C; Ghigo, E; Portioli, I; Procopio, M; Valcavi, R; Valente, F; Zini, M | 1 |
| Arvat, E; Bellone, J; Boffano, GM; Camanni, F; Dentelli, P; Ghigo, E; Maccario, M; Procopio, M; Valente, F | 1 |
| Andò, S; Brancati, C; Bria, M; Caracciolo, M; DeLuca, G; Giorno, A; Lanzino, M; Maggiolini, M; Marsico, S; Salerno, M | 1 |
| Barkan, AL; DeMott-Friberg, R; Jaffe, CA | 1 |
| Aimaretti, G; Arvat, E; Bellone, J; Camanni, F; Ghigo, E; Gianotti, L | 1 |
| Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Davoli, C; Volpi, R | 1 |
| Müller, EE; Rolla, M | 1 |
| Aimaretti, G; Bartolotta, E; Bellone, J; Bellone, S; Camanni, F; Cappa, M; Dammacco, F; Ghigo, E; Loche, S | 1 |
| Aimaretti, G; Arvat, E; Baffoni, C; Camanni, F; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M; Savio, P; Tassone, F; Valetto, MR | 1 |
| Hanew, K; Tanaka, A; Utsumi, A | 1 |
| Aimaretti, G; Arvat, E; Broglio, F; Camanni, F; Ghigo, E; Giordano, R | 1 |
| Grugni, G; Guzzaloni, G; Morabito, F | 2 |
| Aimaretti, G; Arvat, E; Bellone, J; Camanni, F; Corneli, G; Ghigo, E; Maccario, M | 1 |
| Donaubauer, J; Keller, E; Kiess, W; Kratzsch, J; Nowak, T; Steinkamp, H; Willgerodt, H | 1 |
| Hahn, EG; Hoffmann, M; Lohmann, T; Pavel, ME | 1 |
| Andersen, M; Fisker, S; Ørskov, H | 1 |
| Abicht, A; Abuzeid, HA; El-Sadig, SM; Guergueltcheva, V; Huebner, A; Lochmüller, H; Mihaylova, V; Mukhtar, MM; Müller, JS; Nürnberg, G; Salih, MA; von der Hagen, M | 1 |
| Bocchini, S; Cappa, M; Crinò, A; Cuttini, M; Di Giorgio, G; Fintini, D; Grugni, G; Spera, S | 1 |
3 review(s) available for pyridostigmine bromide and arginine
| Article | Year |
|---|---|
Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arginine; Cholinesterase Inhibitors; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Replacement Therapy; Human Growth Hormone; Humans; Middle Aged; Pyridostigmine Bromide | 1998 |
Diagnosis of GH deficiency in adults.
Topics: Adult; Arginine; Dwarfism, Pituitary; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Pyridostigmine Bromide | 1998 |
Diagnosis of growth hormone deficiency.
Topics: Adult; Arginine; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Immunoassay; Insulin; Oligopeptides; Pituitary Diseases; Pyridostigmine Bromide | 2005 |
11 trial(s) available for pyridostigmine bromide and arginine
| Article | Year |
|---|---|
Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine.
Topics: Adolescent; Arginine; Body Height; Child; Child, Preschool; Drug Synergism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Pyridostigmine Bromide; Radioimmunoassay; Somatostatin | 1990 |
Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Topics: Adolescent; Adult; Arginine; Case-Control Studies; Cushing Syndrome; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Middle Aged; Obesity; Pyridostigmine Bromide | 1995 |
Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Arginine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Infusions, Intravenous; Pyridostigmine Bromide; Receptors, Cholinergic | 1994 |
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans.
Topics: Adult; Albuterol; Arginine; Depression, Chemical; Drug Synergism; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Immunoradiometric Assay; Male; Pyridostigmine Bromide; Random Allocation | 1994 |
Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Topics: Adult; Arginine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Hypothyroidism; Kinetics; Male; Middle Aged; Placebos; Pyridostigmine Bromide; Somatostatin | 1993 |
GH secretion in thalassemia patients with short stature.
Topics: Adolescent; Age Determination by Skeleton; Arginine; Body Height; Body Mass Index; Child; Female; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Parasympathomimetics; Pyridostigmine Bromide; Thalassemia | 1995 |
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Topics: Adrenergic alpha-Agonists; Arginine; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Hypoglycemia; Levodopa; Male; Pyridostigmine Bromide; Secretory Rate; Somatostatin | 1996 |
New approach to the diagnosis of growth hormone deficiency in adults.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Male; Middle Aged; Pyridostigmine Bromide | 1996 |
Age-dependent decrease in the growth hormone response to growth hormone-releasing hormone in normally cycling women.
Topics: Adolescent; Adult; Aging; Arginine; Cholinesterase Inhibitors; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Menstrual Cycle; Middle Aged; Pyridostigmine Bromide; Somatostatin | 1996 |
Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Topics: Adolescent; Area Under Curve; Arginine; Child; Drug Interactions; Estrogens; Female; Growth Disorders; Growth Hormone-Releasing Hormone; Growth Substances; Human Growth Hormone; Humans; Male; Oligopeptides; Puberty; Pyridostigmine Bromide | 1998 |
Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome.
Topics: Adrenergic alpha-2 Receptor Agonists; Arginine; Child, Preschool; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Infant; Male; Prader-Willi Syndrome; Pyridostigmine Bromide | 2014 |
18 other study(ies) available for pyridostigmine bromide and arginine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Insulin-Like Growth Factor I; Male; Pituitary Gland; Pyridostigmine Bromide | 1992 |
Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
Topics: Adolescent; Arginine; Child; Drug Synergism; Drug Therapy, Combination; Female; Galanin; Growth Disorders; Growth Hormone; Humans; Levodopa; Male; Neuropeptides; Peptides; Pyridostigmine Bromide | 1990 |
The role of the cholinergic pathway in growth hormone feedback.
Topics: Administration, Oral; Adolescent; Adult; Arginine; Cholinergic Fibers; Feedback; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Male; Pituitary Gland; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Topics: Adolescent; Adult; Arginine; Child; Cholinergic Fibers; Clonidine; Drug Interactions; Female; Growth Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Middle Aged; Obesity; Prolactin; Pyridostigmine Bromide; Synaptic Transmission; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |
Modulation of growth hormone-releasing activity of hexarelin in man.
Topics: Adult; Amino Acid Sequence; Arginine; Evaluation Studies as Topic; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Molecular Sequence Data; Oligopeptides; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1995 |
Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
Topics: Arginine; Child; Clonidine; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Obesity; Pituitary Gland, Anterior; Prolactin; Pyridostigmine Bromide; Receptors, Serotonin; Sumatriptan; Thyrotropin; Thyrotropin-Releasing Hormone | 1995 |
Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children.
Topics: Adolescent; Arginine; Body Height; Drug Synergism; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Propranolol; Pyridostigmine Bromide | 1993 |
Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
Topics: Adolescent; Animals; Anorexia Nervosa; Arginine; Cholinergic Fibers; Dogs; Energy Intake; Female; Food Deprivation; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Muscarinic Antagonists; Neurosecretory Systems; Parasympathomimetics; Pirenzepine; Pyridostigmine Bromide; Receptors, Somatostatin | 1996 |
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Topics: Adolescent; Arginine; Child; Child, Preschool; Clonidine; Exercise; Female; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Pyridostigmine Bromide; Reproducibility of Results | 1996 |
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Topics: Adult; Arginine; Case-Control Studies; Cushing Syndrome; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Male; Middle Aged; Obesity; Pyridostigmine Bromide | 1998 |
Plasma GH responses to GHRH, arginine, L-dopa, pyridostigmine, sequential administrations of GHRH and combined administration of PD and GHRH in Turner's syndrome.
Topics: Adolescent; Adult; Arginine; Body Height; Child; Cholinesterase Inhibitors; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone; Turner Syndrome | 1998 |
Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen.
Topics: Adolescent; Arginine; Body Height; Child; Ethinyl Estradiol; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Kinetics; Male; Oligopeptides; Pyridostigmine Bromide; Sensitivity and Specificity | 1999 |
Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
Topics: Adolescent; Adult; Age of Onset; Arginine; Case-Control Studies; Cholinesterase Inhibitors; Drug Administration Schedule; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Replacement Therapy; Humans; Insulin; Male; Pituitary Gland; Predictive Value of Tests; Pyridostigmine Bromide; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Stimulation, Chemical | 2003 |
Impact of growth hormone on central nervous activity, vigilance, and tiredness after short-term therapy in growth hormone-deficient adults.
Topics: Adaptation, Ocular; Adolescent; Adult; Aged; Arginine; Arousal; Central Nervous System; Fatigue; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pyridostigmine Bromide; Reaction Time; Sleep | 2003 |
Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes.
Topics: Adolescent; Arginine; Cholinesterase Inhibitors; DNA Mutational Analysis; Family Health; Female; Humans; Longitudinal Studies; Male; Mutation; Myasthenic Syndromes, Congenital; Phenotype; Proline; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Young Adult | 2009 |